Studies on the pathophysiology of chronic D-penicillamine-induced myasthenia.
D000818:Animals; D000906:Antibodies / Q000032:analysis; D001667:Binding, Competitive; D002038:Bungarotoxins / Q000378:metabolism; D005260:Female; D006168:Guinea Pigs; D008213:Lymphocyte Activation; D009157:Myasthenia Gravis / Q000139:chemically induced* / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D010396:Penicillamine / Q000009:adverse effects* / Q000494:pharmacology; D011950:Receptors, Cholinergic / Q000276:immunology / Q000378:metabolism; D014101:Torpedo
D000906:Antibodies; D002038:Bungarotoxins; D011950:Receptors, Cholinergic; D010396:Penicillamine